- Patients newly treated for schizophrenia and those receiving continuing treatment will
be eligible if the treating psychiatrist is ready to initiate a new antipsychotic
medication, and would consider using either ziprasidone or olanzapine as an
appropriate therapy.
- Male and female patients who meet all criteria listed below are eligible to be
enrolled in this study:
- Diagnosed with schizophrenia
- Willing to provide information on at least one alternate contact person for study
staff to contact regarding patient's whereabouts, should the patient be
lost-to-follow-up over the course of the study
- Progressive fatal disease of a life expectancy which prohibits them from participating
in a one year research study
- Previously randomized to study medication and enrolled in this study